Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.09.02.748953

Structural Aspects of Nipah Virus Glycoproteins using Predictive Protein Modeling

Abstract

Nipah is a virus borne zoonotic disease that mostly occurs in Southeast Asian countries. Nipah virus (NiV) infection is potentially lethal as it can cause fatal encephalitis, and as of now, there are no vaccines or therapeutic treatments for this disease. The highly pathogenic NiV belongs to the Paramyxovirus family and the natural host of NiV is fruit bats of the Pteropodidae family. Though NiV has not been detected in the US, rather recently the Camp Hill virus (CHV) in shrew species was identified in Camp Hill, Alabama. This virus is characteristically similar to Nipah, and belongs to the henipavirus genus that include the Nipah and Hendra viruses. NiV has two surface glycoproteins namely the attachment glycoprotein (NiVG) and the fusion glycoprotein (NiVF). Being associated with host cell attachment and fusion of viral membrane, these glycoproteins tend to facilitate the viral entry to the host cell. The present paper describes the structures of the aforesaid viral glycoproteins based on the available database of protein structures and examines if they have an evolutionary link to other viral glycoproteins. Certain similar glycoproteins found in different countries are also explored. The structure-function relationship for these two NiV glycoproteins are determined using time-based molecular dynamics (MD) simulation. The interfacial ligand-receptor interactions between NiV proteins with human receptor and monoclonal antibody, Fab 66, are examined. A primary motivation for these structural studies is that the results might potentially contribute to future therapeutic developments and drug designs to effectively combat NiV.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Roy, U.. 2026-09-04. Structural Aspects of Nipah Virus Glycoproteins using Predictive Protein Modeling. https://doi.org/10.64898/2026.09.02.748953

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Deep reinforcement learning-driven discovery of a MsbA-targeted small-molecule antibiotic for the treatment of Acinetobacter baumannii infection

Antibiotics with new mechanisms are highly pursued to address the threat of infections caused by drug-resistant Gram-negative bacteria. Targeting MsbA, a key protein of the lipopolysaccharide biosynthesis pathway, represents a promising strategy to discover new classes of antibiotics. However, currently available MsbA-targeted molecules either lack sufficient potency or have unfavorable properties, necessitating expansion of chemical space. In this study, we chose the most promising cerastecin Cpd 4 as the template, and used two Artificial Intelligence (AI)-based tools, i.e. Link-INVENT and AutoMolDesigner for molecular design, performed chemical derivatization and antibacterial activity evaluation, which led to the discovery of Y-11 (MIC for A. baumannii: 0.5 g/mL). Encouragingly, Y-11 showed equivalent potency to Cpd4 for carbapenem-resistant A. baumannii, and less cytotoxicity and hemolysis as well as lower spontaneous resistance frequency. In vivo efficacy study demonstrated that Y-11 could effectively reduce bacterial loads in the mice infected by A. baumannii. The following mechanism study including molecular dynamics simulation, biochemical assay, and transmission electron microscope (TEM) analysis suggested that Y-11 inhibited the transport of lipooligosaccharide and impaired the formation of outer membrane, probably by competitively binding to the substrate binding site of MsbA and modulating ATPase activity. Taken together, we have discovered a MsbA-targeted small molecule Y-11 via AI-driven drug design, which provides a foundation for future antibiotic development.

biochemistry↗

Dynamic architecture of the Rixosome reveals mechanism of activation and ITS2 processing

Eukaryotic ribosome assembly requires the coordinated processing and extensive remodeling of pre-rRNAs. During late nuclear maturation of the 60S subunit, sequential removal of the internal transcribed spacer 2 (ITS2) is initiated by endonucleolytic cleavage at site C2 by the conserved Las1 nuclease. Las1 acts together with the kinase Grc3 and the Rix1 complex to form the Rixosome, which also functions in transcriptional regulation. However, the assembly of the Rixosome, its recruitment to pre-ribosomes, and its activation for ITS2 cleavage remain unclear. Here, we present cryo-EM structures of the human LAS1 complex, two structures of the isolated Rixosome and nine transition states of Rix1-bound pre-60S particles from Schizosaccharomyces pombe. These structures reveal a dynamic Rixosome architecture in which the heterotetrameric Las1 complex engages one or two copies of the Rix1 complex. Rix1 binding is highly flexible in the human Rixosome but rigid in the yeast complex. The isolated yeast Rixosome remains inactive, but binding to the pre-60S particle triggers a structural rearrangement that allows for substrate engagement and activation of the nuclease. Together, our results define the dynamic architecture of the Rixosome and provide a structural framework for ITS2 processing during nuclear maturation of the eukaryotic 60S ribosomal subunit.

biochemistry↗

SGFP-Grid Split GFP Graphene Grids

Affinity graphene grids provide a promising approach for selective protein capture in cryo-EM. Here, we introduce a split-GFP graphene grid platform(SGFP-G), in which graphene-conjugated GFP 1-10 selectively captures GFP11 tagged proteins from low concentration samples or cell lysates. This platform enables rapid assessment of target protein enrichment and particle distribution before vitrification via fluorescence imaging, while the grid design positions captured proteins away from the graphene surface and air-water interface. We also introduce a unique strategy to minimize nonspecific protein adsorption, thereby improving the selective enrichment of target proteins on this grid. Using GFP11-tagged apoferritin, we demonstrate fluorescence guided protein capture and obtain a 2.58 [A] cryoEM reconstruction, establishing SGFP-G as an affinity grid platform for high resolution structural studies with reduced sample requirements.

biochemistry↗